ISHARES ENERGY STORAGE& MATERIALS ETF IBAT 深 滬
交易中 09-20 11:29:10 美东时间
24.86
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 24.86
- 總市值 696.08万
- 52周最高 25.6978
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 22.15
- 委 比 0.00%
- 總股本 28.00万
- 歷史最高 25.6978
- 量 比 0
- 振 幅 0.00%
- 歷史最低 22.15
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Iris Jancik为IBAT新任首席执行官，推动模块化锂提取技术商业化
国际电池金属有限公司(International Battery Metals Ltd. ，IBAT)宣布其新任首席执行官Iris Jancik已于6月3日上任...
08-21 16:20
Ipsen liver disease drugs endorsed in EU
French drugmaker Ipsen (OTCPK:IPSEY) (OTCPK:IPSEF) announced Friday that an expert panel of the European Medicines Agency recommended marketing authorizations for two of its liver-targeting drugs. Iss...
07-26 22:31
IBAT Launches First Commercial Modular DLE Plant
International Battery Metals (TSE:IBAT) has released an update. International B...
07-12 03:09
iShares Energy Storage & Materials ETF declares semi-annual distribution of $0.1822
iShares Energy Storage & Materials ETF (NASDAQ:IBAT) - $0.1822. Payable June 17; for shareholders of record June 11; ex-div June 11.
06-14 04:35
Why Air Products And Chemicals Shares Are Gaining Today
Air Products and TotalEnergies ink 15-year deal to supply 70,000 tons of green hydrogen annually in Europe, reducing CO2 emissions and supporting TotalEnergies' emissions reduction goals.
06-07 23:27
IBAT Appoints New CEO for Lithium Expansion Drive
International Battery Metals (TSE:IBAT) has released an update. International B...
06-04 05:40
Mirum Announces Publication Of Phase 3 MARCH Data In The Lancet Demonstrating Benefits Of LIVMARLI In patients With PFIC
- Data demonstrate significant benefit across broadest range of genetic PFIC types ever studied- Significant improvements observed across multiple parameters including pruritus, serum bile acids, growth and
05-07 20:30
International Battery Metals Finalizes Major Financing
International Battery Metals (TSE:IBAT) has released an update. International B...
05-07 09:37
International Battery Metals Raises $8.2M for Lithium Project
International Battery Metals (TSE:IBAT) has released an update. International B...
04-27 07:17
Stifel starts Mirum at buy, cites IBATi drug potential
Stifel started coverage of Mirum Pharmaceuticals (NASDAQ:MIRM) with a buy rating, citing the potential of its IBATi drugs. Stifel noted that Mirum has secured FDA approvals for its IBATi drug Livmarli...
04-18 22:39
